IL10 and malaria: Considered together with other studies, including an alternate model of ECM using PccAS-infected IL-10-/- mice in which significantly improved survival was observed following treatment with the LMWH enoxaparin sodium [60], compel future studies to further evaluate the potential therapeutic benefit of anticoagulant therapy during severe malaria.